Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Tight liquidity NBB
Cash and receivables cover 36 % of short-term debt in 2025; threshold 65 %.
-
Busy address KBO
16 other companies have their registered office at the same address; threshold 10.
Financials
Financial year 2025
PHARMACIES BIOT-GYSELINCK from Faimes, company number BE0864202692, closed financial year 2025 with a result of € 205,319 after tax. For that financial year PHARMACIES BIOT-GYSELINCK recorded a gross margin of € 523,761 and equity of € 854,811. Compared with financial year 2024, the result moved from € 149,974 to € 205,319. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on June 17, 2026.
€ 854,811
▲ 14% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 205,319
▲ 37% vs 2024
Profit after tax over the fiscal year.
€ 84,887
▼ 80% vs 2024
Cash and bank balances on the last day of the fiscal year.
€ 100,000 paid out
49 % of the profit went to the shareholders, mostly to PHARMACIE LEJEUNE (100 % of the shares). That is where the money ends up.
People and assets in 2025
3.1
▲ 0.2 vs 2024
Average over the fiscal year, from the social balance sheet.
€ 179,668
▲ 4% vs 2024
€ 58,000 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.
€ 16,290
▲ 117% vs 2024
Book value of vehicles, furniture and equipment.
Debts at end 2025
€ 67,214
▼ 23% vs 2024
€ 20,448 is repaid this year. At this pace the long-term loan is gone in ≈ 3 years.
€ 133,287
▼ 10% vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 35,405
Taxes, VAT and social contributions still to pay.
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € 322,113 | € 378,912 | € 405,471 | € 523,761 | ▲ 29% |
| Profit after taxes | € 86,962 | € 138,894 | € 149,974 | € 205,319 | ▲ 37% |
| Equity | € 460,624 | € 599,519 | € 749,492 | € 854,811 | ▲ 14% |
| Total debts | € 213,614 | € 192,859 | € 595,744 | € 659,412 | ▲ 11% |
| Cash | € 185,484 | € 269,227 | € 415,423 | € 84,887 | ▼ 80% |
| Land & buildings | € 283,984 | € 267,713 | € 251,442 | € 581,784 | ▲ 131% |
| Retained profit | € 410,624 | € 549,519 | € 699,492 | € 804,811 | ▲ 15% |
| Dividend | € 0 | € 0 | € 0 | € 100,000 | |
| Bank debt | € 127,341 | € 107,500 | € 87,458 | € 67,214 | ▼ 23% |
| Balance sheet total | € 674,239 | € 792,378 | € 1,345,236 | € 1,514,223 | ▲ 13% |
| Employees (FTE) | 3.9 | 2.9 | 2.9 | 3.1 | ▲ 0.2 |
By gross margin, PHARMACIES BIOT-GYSELINCK ranks 3rd of 15 companies with main activity “Detailhandel in farmaceutische producten” in Faimes that publish figures (fiscal year 2025).
Key figures of PHARMACIES BIOT-GYSELINCK, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
Ask about PHARMACIES BIOT-GYSELINCK the way you would ask their accountant.
Answers from the filed annual accounts, the Belgian Official Gazette and the CBE register.
Connect ChatGPT or Claude for free- ChatGPT
- Claude
Free account, no payment card. Key figures unlimited, the annual accounts and deeds of 10 companies a month. Need more? Get in touch, we are looking for our first pilot users.
What happened to PHARMACIES BIOT-GYSELINCK?
What happened at PHARMACIES BIOT-GYSELINCK in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 205,319 (▲ 37% vs 2024). Source: NBB ↗
- New establishment in Marchin. KBO
- Start of the company according to the CBE. KBO
- New establishment in Marchin. KBO
In short
From € 86,962 profit in 2022 to € 205,319 profit in 2025.
Paid € 203,381 in corporate taxes since 2022.
Best year ever: 2025, with € 205,319 profit.
On average € 169,000 of value added per employee in 2025.
Management
The stake of PHARMACIE LEJEUNE comes from that shareholder’s own annual accounts; small companies do not report their shareholders themselves.
PHARMACIES BIOT-GYSELINCKBehind PHARMACIES BIOT-GYSELINCK is PHARMACIE LEJEUNE SA. The shares are held by PHARMACIE LEJEUNE (100%).
Directors
According to the 2025 annual accounts
Director · represented by François-Xavier OLIVIER
Also active at: PHARMACIE BEAUMONT, Pharmacie J.P. Detry - Discry, PHARMACIE DES FORGES, PHARMACIE DE DONCEEL, PHARMACIE DUBOIS-HUSSON, Pharmacie DETRY-DUPONT, PHARMACIE R. WALNIER, Pharmacie BILLEN +10 more
Shareholders
100%
Participations
No participations in other companies reported.
Establishments
Establishment units
Physical locations of this company
Rue de la Champignotte(AIN) 13
4317 Faimes
Place de Belle-Maison 20
4570 Marchin
Active since 11 March 2004
Rue Joseph Wauters 12 box bis
4570 Marchin
Active since 1 September 2024
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 16 companies are registered at this address.
All companies at this address →Pharmacie J.P. Detry - Discry same network
€ 255,389 gross margin · 2025
PHARMACIE DE DONCEEL same network
€ 175,420 gross margin · 2025
PHARMACIE DUBOIS-HUSSON same network
€ 475,076 gross margin · 2025
Pharmacie DETRY-DUPONT same network
€ 297,327 gross margin · 2025
PHARMACIE R. WALNIER same network
€ 463,240 gross margin · 2025
+11 more
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Similar companies in Faimes
Same main activity (Detailhandel in farmaceutische producten), 16 active companies in Faimes, largest first.
€ 12.4 million revenue · 2025
€ 703,993 gross margin · 2025
€ 528,584 gross margin · 2025
€ 475,076 gross margin · 2025
€ 463,240 gross margin · 2025
€ 404,904 gross margin · 2025
Details
- Company number
- 0864.202.692
- VAT number
- BE 0864.202.692
- Registered office
- Rue de la Champignotte(AIN) 13, 4317 Faimes
- Names & denominations
- PHARMACIES BIOT-GYSELINCK
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 22 March 2004
- Peppol
- Active · Active since 10 Sept 2025
- Activities · NACE
Detailhandel in farmaceutische producten
Apothekers